These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 34350062)
1. DGKζ exerts greater control than DGKα over CD8 Gu J; Wang C; Cao C; Huang J; Holzhauer S; Desilva H; Wesley EM; Evans DB; Benci J; Wichroski M; Wee S; Riese MJ Oncoimmunology; 2021; 10(1):1941566. PubMed ID: 34350062 [TBL] [Abstract][Full Text] [Related]
2. The ζ isoform of diacylglycerol kinase plays a predominant role in regulatory T cell development and TCR-mediated ras signaling. Joshi RP; Schmidt AM; Das J; Pytel D; Riese MJ; Lester M; Diehl JA; Behrens EM; Kambayashi T; Koretzky GA Sci Signal; 2013 Nov; 6(303):ra102. PubMed ID: 24280043 [TBL] [Abstract][Full Text] [Related]
4. Predominant contribution of DGKζ over DGKα in the control of PKC/PDK-1-regulated functions in T cells. Ávila-Flores A; Arranz-Nicolás J; Andrada E; Soutar D; Mérida I Immunol Cell Biol; 2017 Jul; 95(6):549-563. PubMed ID: 28163304 [TBL] [Abstract][Full Text] [Related]
5. Diacylglycerol kinase ζ controls diacylglycerol metabolism at the immunological synapse. Gharbi SI; Rincón E; Avila-Flores A; Torres-Ayuso P; Almena M; Cobos MA; Albar JP; Mérida I Mol Biol Cell; 2011 Nov; 22(22):4406-14. PubMed ID: 21937721 [TBL] [Abstract][Full Text] [Related]
6. Diacylglycerol kinase α inactivation is an integral component of the costimulatory pathway that amplifies TCR signals. Arranz-Nicolás J; Ogando J; Soutar D; Arcos-Pérez R; Meraviglia-Crivelli D; Mañes S; Mérida I; Ávila-Flores A Cancer Immunol Immunother; 2018 Jun; 67(6):965-980. PubMed ID: 29572701 [TBL] [Abstract][Full Text] [Related]
7. Diacylglycerol kinase ζ limits IL-2-dependent control of PD-1 expression in tumor-infiltrating T lymphocytes. Arranz-Nicolás J; Martin-Salgado M; Rodríguez-Rodríguez C; Liébana R; Moreno-Ortiz MC; Leitner J; Steinberger P; Ávila-Flores A; Merida I J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33246984 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-34a enhances T cell activation by targeting diacylglycerol kinase ζ. Shin J; Xie D; Zhong XP PLoS One; 2013; 8(10):e77983. PubMed ID: 24147106 [TBL] [Abstract][Full Text] [Related]
9. Decreased diacylglycerol metabolism enhances ERK activation and augments CD8+ T cell functional responses. Riese MJ; Grewal J; Das J; Zou T; Patil V; Chakraborty AK; Koretzky GA J Biol Chem; 2011 Feb; 286(7):5254-65. PubMed ID: 21138839 [TBL] [Abstract][Full Text] [Related]
10. Combined inhibition/silencing of diacylglycerol kinase α and ζ simultaneously and synergistically enhances interleukin-2 production in T cells and induces cell death of melanoma cells. Takao S; Akiyama R; Sakane F J Cell Biochem; 2021 May; 122(5):494-506. PubMed ID: 33399248 [TBL] [Abstract][Full Text] [Related]
11. Enhanced effector responses in activated CD8+ T cells deficient in diacylglycerol kinases. Riese MJ; Wang LC; Moon EK; Joshi RP; Ranganathan A; June CH; Koretzky GA; Albelda SM Cancer Res; 2013 Jun; 73(12):3566-77. PubMed ID: 23576561 [TBL] [Abstract][Full Text] [Related]
12. Negative control of diacylglycerol kinase ζ-mediated inhibition of T cell receptor signaling by nuclear sequestration in mice. Xie D; Zhang S; Chen P; Deng W; Pan Y; Xie J; Wang J; Liao B; Sleasman JW; Zhong XP Eur J Immunol; 2020 Nov; 50(11):1729-1745. PubMed ID: 32525220 [TBL] [Abstract][Full Text] [Related]
13. Diacylglycerol Kinase alpha in X Linked Lymphoproliferative Disease Type 1. Velnati S; Centonze S; Girivetto F; Baldanzi G Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072296 [TBL] [Abstract][Full Text] [Related]
15. The expression of diacylglycerol kinase isoforms α and ζ correlates with the progression of experimental autoimmune encephalomyelitis in rats. Cui H; Huang Y; Wu Y; Ma J; Cao X; Xie J; Zhang Y Histochem Cell Biol; 2021 Nov; 156(5):437-448. PubMed ID: 34312706 [TBL] [Abstract][Full Text] [Related]
16. Diacylglycerol Kinases (DGKs): Novel Targets for Improving T Cell Activity in Cancer. Riese MJ; Moon EK; Johnson BD; Albelda SM Front Cell Dev Biol; 2016; 4():108. PubMed ID: 27800476 [TBL] [Abstract][Full Text] [Related]
18. DGKα/ζ inhibitors combine with PD-1 checkpoint therapy to promote T cell-mediated antitumor immunity. Wichroski M; Benci J; Liu SQ; Chupak L; Fang J; Cao C; Wang C; Onorato J; Qiu H; Shan Y; Banas D; Powles R; Locke G; Witt A; Stromko C; Qi H; Zheng X; Martin S; Ding M; Gentles R; Meanwell N; Velaparthi U; Olson R; Wee S; Tenney D; Parker CG; Cravatt BF; Lawrence M; Borzilleri R; Lees E Sci Transl Med; 2023 Oct; 15(719):eadh1892. PubMed ID: 37878674 [TBL] [Abstract][Full Text] [Related]
19. Synergistic control of T cell development and tumor suppression by diacylglycerol kinase alpha and zeta. Guo R; Wan CK; Carpenter JH; Mousallem T; Boustany RM; Kuan CT; Burks AW; Zhong XP Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11909-14. PubMed ID: 18689679 [TBL] [Abstract][Full Text] [Related]
20. Graded diacylglycerol kinases α and ζ activities ensure mucosal-associated invariant T-cell development in mice. Pan Y; Deng W; Xie J; Zhang S; Wan ECK; Li L; Tao H; Hu Z; Chen Y; Ma L; Gao J; Zhong XP Eur J Immunol; 2020 Feb; 50(2):192-204. PubMed ID: 31710099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]